Daewoong Pharma (069620) — Cash Flow Reinvestment Rate
Daewoong Pharma (069620) has a Cash Flow Reinvestment Rate of 1.26x as of September 2025, reinvesting ₩72.66 Billion (capex ₩72.21 Billion plus investments ₩-447.40 Million) from operating cash flow of ₩57.53 Billion. See 069620 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Daewoong Pharma Cash Flow Reinvestment Rate (2007–2024)
Historical reinvestment intensity for Daewoong Pharma across 16 annual periods. For the full cash flow conversion analysis, see Daewoong Pharma (069620) cash conversion ratio.
Annual Cash Flow Reinvestment Rate for Daewoong Pharma (2007–2024)
Year-by-year capital reinvestment analysis for Daewoong Pharma. See Daewoong Pharma financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 5.11x | ₩263.16 Billion | ₩51.49 Billion | ₩229.00 Billion | ▲ +120.7% |
| 2023 | 2.32x | ₩306.94 Billion | ₩132.57 Billion | ₩118.67 Billion | ▲ +279.0% |
| 2022 | 0.61x | ₩72.21 Billion | ₩118.21 Billion | ₩65.23 Billion | ▼ -42.3% |
| 2021 | 1.06x | ₩42.31 Billion | ₩39.99 Billion | ₩29.09 Billion | ▼ -6.4% |
| 2020 | 1.13x | ₩114.07 Billion | ₩100.98 Billion | ₩26.49 Billion | ▲ +7.3% |
| 2019 | 1.05x | ₩60.66 Billion | ₩57.60 Billion | ₩22.31 Billion | ▼ -33.4% |
| 2018 | 1.58x | ₩75.09 Billion | ₩47.50 Billion | ₩56.99 Billion | ▲ +77.9% |
| 2017 | 0.89x | ₩92.38 Billion | ₩103.94 Billion | ₩69.12 Billion | ▼ -95.7% |
| 2016 | 20.75x | ₩319.02 Billion | ₩15.38 Billion | ₩163.25 Billion | ▲ +506.1% |
| 2015 | 3.42x | ₩122.84 Billion | ₩35.89 Billion | ₩95.13 Billion | ▼ -29.9% |
| 2014 | 4.89x | ₩126.78 Billion | ₩25.95 Billion | ₩46.00 Billion | ▲ +343.6% |
| 2013 | 1.10x | ₩59.65 Billion | ₩54.16 Billion | ₩19.04 Billion | ▲ +108.6% |
| 2012 | 0.53x | ₩23.77 Billion | ₩45.02 Billion | ₩23.77 Billion | ▲ +1.7% |
| 2011 | 0.52x | ₩40.92 Billion | ₩78.82 Billion | ₩40.92 Billion | ▼ -54.0% |
| 2008 | 1.13x | ₩35.35 Billion | ₩31.33 Billion | ₩35.35 Billion | ▼ -18.8% |
| 2007 | 1.39x | ₩35.89 Billion | ₩25.81 Billion | ₩35.89 Billion | — |